Global DNA Testing Market Trends and Growth Analysis 2025–2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Does The Market Size Of The DNA Testing Industry Compare Between 2025 And 2029?

The dna testing market size has experienced swift expansion in recent years. Its value is anticipated to rise from $17.9 billion in 2024 to $20.04 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 12.0%. The past growth in this market stems from several factors, including the increasing occurrence of chronic diseases, a growing need for precision medicine, an increase in direct-to-consumer (DTC) testing, heightened interest in population genomics, more frequent forensic investigations, and the requirement for genetic screening.

The dna testing market size is anticipated to experience substantial growth over the next few years. It is projected to expand to $30.25 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 10.8%. This expansion during the forecast period can be attributed to factors such as rising occurrences of genetic diseases, the increasing utilization of DNA diagnostics, improvements in healthcare infrastructure, growing awareness concerning disease prevention, elevated investment from manufacturers, and wider adoption of companion diagnostics. Prominent trends within the forecast period include next-generation sequencing (NGS), polymerase chain reaction (PCR), preimplantation genetic diagnosis (PGD) within assisted reproductive technologies (art), the miniaturization of testing devices, the introduction of new DNA testing products, and the ongoing development of novel assays, biomarkers, diagnostic tools, point-of-care testing, and non-invasive prenatal testing (NIPT).

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15358&type=smp

Which Major Market Drivers Are Shaping The Future Of The DNA Testing Market?

The projected expansion of the DNA testing market is anticipated due to the growing occurrence of genetic disorders. These disorders are conditions resulting from DNA irregularities within an individual, often leading to physical or developmental issues. Several factors contribute to the rising frequency of genetic disorders, including heightened awareness, enhanced diagnostic methods, broader genetic screening programs, and the increasing practice of consanguineous marriages in certain communities. Increasingly, DNA testing is employed for diagnosing, forecasting, and informing treatment choices for those with genetic disorders, facilitating tailored medical treatment and family planning approaches determined by an individual’s genetic composition. For example, data from February 2023, provided by the World Health Organization (WHO), a United Nations specialized agency based in Switzerland focusing on international public health, indicated that congenital diseases were responsible for approximately 240,000 baby deaths worldwide annually within 28 days of birth. Furthermore, statistics from the US-based government agency, the Centers for Disease Control and Prevention, show that around 6,000 babies are born with Down syndrome annually in the United States, equating to roughly 1 in every 700 babies. Consequently, the growing occurrence of genetic disorders serves as a primary impetus for the DNA testing market.

What Are The Major Segment Types Covered In The DNA Testing Market?

The dna testingmarket covered in this report is segmented –

1) By Product Type: Equipment; Consumables; Software And Services

2) By Technology: Polymerase Chain Reaction (PCR) Based; In-Situ Hybridization; Microarray; Next-Generation Sequencing (NGS) DNA Diagnosis

3) By Application: Newborn DNA Screening; Pre-Natal DNA Carrier Screening; Oncology Diagnostics And Histopathology; Pre-implantation Diagnosis; Infectious Disease Diagnostics; Pharmacogenomics Diagnostic Testing; Identify Diagnostics And Forensic; Other Applications

Subsegments:

1) By Equipment: DNA Analyzers; PCR (Polymerase Chain Reaction) Machines; Sequencers; Electrophoresis Systems; Other DNA Testing Instruments

2) By Consumables: Reagents And Kits; PCR Consumables (Primers, Probes); DNA Extraction Kits; Sample Collection Devices; Others (DNA Markers, Electrophoresis Gels)

3) By Software: Data Analysis Software; Laboratory Information Management System (LIMS); Genetic Analysis Software; Bioinformatics Software; Other DNA Testing Software Solutions

4) By Services: Testing Services (Genetic Testing, Forensic Testing, Etc.); Data Interpretation Services; Consultation Services (Genetic Counseling); Laboratory Services (Sample Processing, DNA Sequencing Services); Other DNA Testing Services

What Are The Latest Industry Trends Transforming The DNA Testing Market?

Leading companies in the DNA testing market are focused on developing advanced testing solutions, such as precancer detection DNA tests, to improve the early diagnosis and treatment of cancer. Precancer detection DNA tests are diagnostic assays designed to identify genetic alterations or biomarkers associated with the early stages of cancer development. For instance, in November 2023, Lucid Diagnostics Inc., a US-based esophageal cancer prevention medical diagnostics company, launched a next-generation EsoGuard Esophageal DNA Test known as EsoGuard 2.0. This advanced esophageal DNA test utilizes molecular techniques and improved sample DNA yields to enhance assay performance and reduce costs. The test involves collecting DNA from esophageal cells using the EsoCheck Cell Collection Device, followed by bisulfite conversion, polymerase chain reaction (PCR) amplification, and next-generation sequencing to identify methylation at specific sites on genes associated with esophageal precancer and cancer. This DNA test provides results indicating the presence or absence of epigenetic changes consistent with esophageal precancer and cancer. It is an essential DNA testing tool in cancer prevention and early detection.

Which Key Players Are Driving Competition In The DNA Testing Market?

Major companies operating in the DNA testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers GmbH, Becton, Dickinson and Company, GE HealthCare Technologies Inc., Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies, Illumina Inc., PerkinElmer Inc., bioMérieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., Cepheid, NeoGenomics Laboratories Inc., Ancestry.com LLC, 23andMe Holding Co, Ambry Genetics Corporation, MyHeritage Ltd., Biocartis SA, CENTOGENE N.V., Everlywell Inc., Atlas Biomed Group Limited, Veritas Genetics

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/dna-testing-global-market-report

Which Region Currently Holds The Largest Share Of The DNA Testing Market?

North America was the largest region in the DNA testing market in 2024. The regions covered in the DNA testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The DNA Testing Market Report:

https://www.thebusinessresearchcompany.com/customise?id=15358&type=smp

Browse Through More Reports Similar to the Global DNA Testing Market 2025, By The Business Research Company

Prenatal Dna Sequencing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/prenatal-dna-sequencing-global-market-report

Viral Vectors And Plasmid Dna Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/viral-vectors-and-plasmid-dna-global-market-report

Recombinant Dna Technology Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/recombinant-dna-technology-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795